期刊文献+

国内医疗器械临床试验现状的分析 被引量:12

Analysis of current situation of medical device clinical trial in China
原文传递
导出
摘要 近年来,医疗器械临床试验开展数量上升趋势明显,为此国家药品监督管理局针对医疗器械临床试验进行了一系列的改革措施,监管路径也越趋规范和严格。本文主要从临床试验机构角度针对目前国内医疗器械临床试验的现状,从机构分布、监督管理、风险管理和行业不足几方面进行总结和分析,旨在为参与临床试验的各方提供参考。 In recent years,with the quantity increased significantly,more and more problems arisen in medical device clinical trials.Therefore,the National Medical Products Administration had carried out a series of reform measures for it,and the regulation measures was becoming more standardized and stringent.To provide reference for all parties involved in the implementation of clinical trials,this article summarizes and considers the current status of medical device clinical trial in China,including the distribution of institution,supervision,risk management and current shortcomings.
作者 李文适 陈文华 李强 贺帅 LI Wen-shi;CHEN Wen-hua;LI Qiang;HE Shuai(Pharmacy Department,Zhujiang Hospital of Southern Medical University,Guangzhou 510280,Guangdong Province,China;Guangzhou Boji Medical Biotechnological Co.Ltd.,Guangzhou 510640,Guangdong Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2019年第19期2448-2451,共4页 The Chinese Journal of Clinical Pharmacology
关键词 医疗器械 医疗器械临床试验 临床试验机构 风险管理 medical device medical device clinical trial clinical trial institution risk management
  • 相关文献

参考文献11

二级参考文献62

  • 1宋苹,唐雪春,梁伟雄,张勋.建立“三级质控”体系,提高药物临床试验质量[J].中国新药杂志,2005,14(7):896-897. 被引量:24
  • 2国家食品药品监督管理总局.药物临床试验机构资格认定办法(试行)[EB/OL].[2015-08-10].http://www.sda.gov.en/WS01/CL0058/9346.html.
  • 3MENDIS S, JOHNSTON SC, FAN W et al. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial[ J ]. Bull World Health Organ, 2010, 85 (6) :412 - 419.
  • 4GUPTA A. Taking the ' Risk' out of risk-based monitoring [ J ]. Perspect Clin Res, 2013, 4(4) :193 -195.
  • 5SMITH CT, WILLIAMSON P, JONES A,et al. Risk-proportionate clinical trial monitoring: an example approach from a noncommercial trials unit[J]. Trials, 2014, 15:127.
  • 6JAKKALA L. Reflection paper on clinical oversight in the light of regulatory perspective and quality risk management [ J ]. Biosci Biotech Res Comm, 2013, 6(2) : 158 -162.
  • 7International Organization for Standardization. ISO 14971:2007 Medical devices -- Application of risk management to medical devices [ EB/OL]. [ 2015 - 08 - 10 ]. https://www, iso. org/ obp/ui/#iso : std : iso : 14971 : ed - 2 : v2 : en.
  • 8国家食品药品监督管理总局.YY/T0316-2008/ISO14971:2007医疗器械风险管理对医疗器械的应用[S].2015.
  • 9Food and Drug Administration. Guidance for Industry Oversight of Clinical Investigations A Risk-Based Approach to Monitoring [ EB/OL]. [ 2015 - 08 - 10]. http ://www. fda. gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ ucm269919, pdf.
  • 10International Organization for Standardization. ISO 31000:2009 Risk management-Principles and guidelines [EB/OL]. [2015 - 08 - 10 ]. https://www, iso. org/obp/ui/#iso : std :iee : 31010 : ed-1 :vl :en.

共引文献115

同被引文献116

引证文献12

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部